Walleye Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$371K Sell
7,100
-4,200
-37% -$252K ﹤0.01% 2893
2025
Q4
$665K Buy
11,300
+3,300
+41% +$201K ﹤0.01% 2757
2025
Q3
$445K Buy
8,000
+3,800
+90% +$204K ﹤0.01% 2715
2025
Q2
$216K Buy
+4,200
New +$211K ﹤0.01% 3306
2024
Q4
Sell
-14,100
Closed -$1.13M 5547
2024
Q3
$1.13M Sell
14,100
-6,200
-31% -$466K ﹤0.01% 2536
2024
Q2
$1.45M Buy
20,300
+9,600
+90% +$707K ﹤0.01% 2435
2024
Q1
$753K Buy
10,700
+5,200
+95% +$372K ﹤0.01% 2849
2023
Q4
$424K Buy
+5,500
New +$362K ﹤0.01% 3079
2023
Q3
Sell
-12,700
Closed -$1.04M 5321
2023
Q2
$1.04M Sell
12,700
-2,400
-16% -$193K ﹤0.01% 1819
2023
Q1
$1.12M Buy
15,100
+14,700
+3,675% +$1.13M 0.02% 1079
2022
Q4
$33.2K Buy
+400
New +$31.8K ﹤0.01% 2593

Other funds holding TECH

Walleye Capital's TECH Position: Q1 2026 in Review

Walleye Capital reduced its Bio-Techne (TECH) stake by 5.7% in Q1 2026, selling an estimated $484K and leaving 132,407 shares worth $6.92M. The position accounts for 0.03% of the portfolio, ranked #599.

Walleye Capital first reported a position in TECH in Q1 2022 and has held it in 10 quarters since. The position peaked at $24.7M in Q3 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Walleye Capital held 132,407 shares of Bio-Techne worth $6.92M as of Q1 2026.
  • Walleye Capital sold 8,061 Bio-Techne shares in Q1 2026, an estimated $484K.
  • Bio-Techne made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #599 holding.
  • Walleye Capital first reported a position in Bio-Techne in Q1 2022 and has held it in 10 quarters since.
  • Walleye Capital's Bio-Techne position peaked at $24.7M in Q3 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.